We’re proud to announce that Mosaic Design Labs has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). This funding will accelerate development of our revolutionary microfluidic automation platform.
Project Overview: Microfluidic Automation Platform
Our NIH-funded project focuses on developing an integrated platform that combines:
Advanced Microfluidics
Precision-engineered microfluidic devices that enable complex biological assays with minimal sample volumes and reduced reagent costs.
AI-Driven Automation
Intelligent control systems that optimize assay parameters in real-time, ensuring consistent results while adapting to varying sample conditions.
User-Friendly Interface
Intuitive software that makes sophisticated microfluidic protocols accessible to researchers without specialized training.
Impact on Biomedical Research
This platform addresses critical challenges in biomedical research:
- Sample Efficiency: Reducing required sample volumes by up to 90%
- Cost Reduction: Minimizing reagent usage and waste
- Standardization: Ensuring reproducible results across different laboratories
- Accessibility: Making advanced microfluidic techniques available to smaller research groups
Why This Matters
The NIH SBIR program is highly competitive, with funding awarded only to projects that demonstrate exceptional scientific merit and commercial potential. This recognition validates our approach to biomedical innovation and positions us to make a significant impact on research capabilities worldwide.
Looking Ahead
Phase I funding will enable us to:
- Complete proof-of-concept demonstrations
- Validate key performance metrics
- Develop partnerships with leading research institutions
- Prepare for Phase II expansion
We’re already seeing strong interest from potential collaborators and early adopters, setting the stage for successful commercialization.
Our Commitment to Research Excellence
This SBIR award reinforces our mission to develop technologies that empower researchers to make breakthrough discoveries. By combining cutting-edge engineering with deep understanding of laboratory workflows, we’re creating tools that truly serve the biomedical community.
Interested in learning more about our microfluidic automation platform or exploring collaboration opportunities? Contact our team today.